STA
IDXX icon

Summit Trail Advisors’s Idexx Laboratories IDXX Stock Holding History

Summit Trail Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.13M Buy
3,784
+494
+15% +$317K 0.03% 478
2025
Q4 		$2.23M Sell
3,290
-211
-6% -$144K 0.04% 349
2025
Q3 		$2.24M Buy
3,501
+786
+29% +$477K 0.03% 387
2025
Q2 		$1.46M Buy
2,715
+1,474
+119% +$705K 0.03% 350
2025
Q1 		$521K Buy
1,241
+431
+53% +$187K 0.02% 250
2024
Q4 		$335K Buy
810
+26
+3% +$11.4K 0.01% 273
2024
Q3 		$396K Buy
784
+81
+12% +$39.4K 0.01% 459
2024
Q2 		$343K Sell
703
-98
-12% -$49.2K 0.01% 447
2024
Q1 		$432K Buy
801
+300
+60% +$164K 0.01% 369
2023
Q4 		$278K Sell
501
-61
-11% -$28.6K 0.01% 417
2023
Q3 		$246K Buy
562
+68
+14% +$33.9K 0.01% 440
2023
Q2 		$248K Buy
+494
New +$237K 0.01% 417
2022
Q2 		– Sell
-760
Closed -$416K – 398
2022
Q1 		$416K Buy
+760
New +$400K 0.03% 199
2018
Q1 		– Sell
-86
Closed -$16K – 1012
2017
Q4 		$16K Buy
+86
New +$13.5K ﹤0.01% 1102

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Summit Trail Advisors's IDXX Position: Q1 2026 in Review

Summit Trail Advisors increased its Idexx Laboratories (IDXX) stake by 15% in Q1 2026, buying an estimated $317K and bringing the position to 3,784 shares worth $2.13M. The position accounts for 0.03% of the portfolio, ranked #478.

Summit Trail Advisors first reported a position in IDXX in Q4 2017 and has held it in 14 quarters since. The position peaked at $2.24M in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Summit Trail Advisors held 3,784 shares of Idexx Laboratories worth $2.13M as of Q1 2026.
  • Summit Trail Advisors bought 494 Idexx Laboratories shares in Q1 2026, an estimated $317K.
  • Idexx Laboratories made up 0.03% of Summit Trail Advisors's portfolio in Q1 2026, its #478 holding.
  • Summit Trail Advisors first reported a position in Idexx Laboratories in Q4 2017 and has held it in 14 quarters since.
  • Summit Trail Advisors's Idexx Laboratories position peaked at $2.24M in Q3 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.